LONDON, July 4, 2016 /PRNewswire/ -- This BCC Research report analyzes the advanced drug delivery market by technologies/systems, applications, routes of administration and drug delivery vehicles. Forecast given for the period 2015-2020.
Use this report to:
Identify the market dynamics of global advanced drug delivery technologies and their relevant business impact.
Gain insight into the advanced drug delivery industry competitive landscape.
Analyze the advanced drug delivery market by technology, application, routes of administration, and drug delivery vehicle.
Gain information through patents on advanced drug delivery systems.
The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%.
The North American market should grow from nearly $75.7 billion in 2015 to $93.4 billion by 2020, a CAGR of 4.3%.
The European market should grow from roughly $57.3 billion in 2015 to nearly $72.1 billion by 2020, a CAGR of 4.7%.
STUDY GOALS AND OBJECTIVES
The study's goal is to provide industry participants insights into the global advanced drug delivery technologies market, both in terms of quantitative and qualitative data, which could help them gain an understanding of the market to develop business/growth strategies, assess the landscape, analyze their current position and make more informed business decisions. In particular, the study's objectives include the following:
Provide comprehensive analysis of advanced drug delivery technologies, applications, routes of administration and drug delivery vehicles.
Identify the market dynamics of each key market and the relevant business impact hereof.
Offer market forecasting for four regions: North America, Europe, Asia and rest of the world (ROW).
Report and analyze key market developments.
Highlight and analyze market trends, drivers and restraints.
Analyze each key region listed above.
Analyze the market's competitive landscape.
REASONS FOR DOING THE STUDY
Advances in medical science, research and development (R&D), and innovation are changing the dynamics of the life sciences industry, including biotechnology, pharmaceuticals and healthcare. The development of new drugs necessitates the development of different drug delivery systems, which is further driven by innovation in technology, R&D and scientific advancements.
Advances in understanding human biology, diseases and medical treatments are opening new opportunities in the pharmaceutical industry. A drug delivery system is an important area where the need for better technologies for drug administration/delivery is in demand.
A key driver of the growth in this industry is the advantages advanced drug delivery systems offer over traditional drug delivery systems, such as higher efficacy, localized treatment of diseases, duration of drug delivery, convenient routes of administration, better targeting and lower dosing frequency. For example, advanced drug delivery systems such as rectal drug delivery, lymphatic implants are more effective than traditional pharmaceuticals and promote better treatment outcomes (e.g., fewer side effects, continuous or extended release of the drug). Consequently, these developments are driving significant growth in the global drug delivery market.
Currently, the global market for advanced drug delivery systems is valued at over $150 billion. This report offers an overview of current and future market characteristics of advanced drug delivery systems. It provides a comprehensive view of current and emerging drug delivery technologies, market drivers and restraints, the competitive landscape, and market revenues by technology across different regions (the United States, Europe, Asia and ROW).
Download the full report: https://www.reportbuyer.com/product/1940407/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-markets-and-technologies-for-advanced-drug-delivery-systems-300293744.html